Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Inmune Bio, Inc. publishes a filing, an earnings call transcript or a press release.

Get INMB alerts

About Mark Lodell

Mark Lodell has spoken on 1 earnings call across 1 company, most recently for Inmune Bio, Inc. on November 5, 2026. Inmune Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Inmune Bio, Inc. includes David J. Moss (CEO and Board Member), J. Kelly Ganjei (Chairman), Cory Ellspermann (Board Member) and 7 others.

Mark Lodell on recent calls

“So, this is another quarter in which we've made substantial progress in bringing Ebstracell towards marketing approval, as David's alluded to, and I remain highly confident in the strength of the applications we're putting together.”
Other, INmune Bio Inc. Announces Third Quarter 2026 Results and Provides Business Update ·

Affiliation history

Company network

Leadership on record at Inmune Bio, Inc.

Recent activity